U.S. pharma huge copyright scrapped two experimental weight loss supplements past calendar year—a after-each day pill, lotiglipron, on account of elevated liver enzymes plus a 2 times-day by day pill, danuglipron, due to strong Unwanted effects—but CEO Albert Bourla has said the company is set to “Engage in and gain” during the weight probl